ARCHIVES

Predicant, Correlogic executives contradict scientists’ claim that firms didn’t appear to compete.

This article is from The Cancer Letter archive.

Vol. 30 No. 26 | June 25, 2004

Download PDF Visit The Full Archive

Related Articles

NCI Board of Scientific Advisors rejects the Institute’s $89 million proteomics research plan.

March 11, 2005

In Brief: Goldman Named Director, Albert Einstein Cancer Center; Wiernik Resumes Post

October 20, 1995

NCI T Fund New Effort By Cooperative Groups To Extend Treatment Into Community Hospitals

March 5, 1976

In Brief: Weiner Elected President-Elect of AACI

February 15, 2013

NCI Closes Iressa Trial For NSCLC When Data Indicate No Survival Benefit

April 29, 2005

Interim Analysis Suggests Paclical Can Reduce Blood Levels

August 26, 2011